Clinical Trial Update: Zinc and Green Tea Extract for Community Respiratory Viral Infections [Phase 2]

View source ↗

Summary

Phase 2 trial of zinc and green tea extract for community respiratory viral infections was terminated, with results posted in March 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)
• ZINC (Zinc chloride)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Respiratory Viral Infection | Phase 2 | Status: TERMINATED | Results posted: 2025-03-07